SCHEMBL6283849

SCHEMBL6283849

COC(=O)c1cccc(OC(C)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.54
TP53 P04637 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.51
RAB9A P51151 4/20 0.50
NPC1 O15118 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.50
MEN1 O00255 1/20 0.50
PKM P14618 1/20 0.50
HPGD P15428 1/20 0.50
MAPK1 P28482 1/20 0.50
KMT2A Q03164 1/20 0.50
CYP4F2 P78329 1/20 0.49
CYP4A11 Q02928 1/20 0.49
CES2 O00748 1/20 0.49
CES1 P23141 1/20 0.49
PRSS1 P07477 1/20 0.48
ACR P10323 1/20 0.48
POLB P06746 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27672005 0.88 SMN1; SMN2 (0.55) SMN1; SMN2TP53L3MBTL1RAB9ANPC1
SCHEMBL6174966 0.88 SMN1; SMN2 (0.59) SMN1; SMN2TP53L3MBTL1RAB9ANPC1
SCHEMBL8795241 0.85 SMN1; SMN2 (0.52) SMN1; SMN2TP53L3MBTL1RAB9ANPC1
SCHEMBL321520 0.83 TSHR (0.52) SMN1; SMN2TP53L3MBTL1RAB9ANPC1
SCHEMBL6285471 0.83 MAPT (0.55) L3MBTL1ALDH1A1MEN1PKMMAPK1
SCHEMBL7944868 0.83 SMN1; SMN2 (0.51) SMN1; SMN2TP53L3MBTL1RAB9ANPC1
SCHEMBL320845 0.83 TSHR (0.52) SMN1; SMN2TP53L3MBTL1RAB9ANPC1
SCHEMBL30744976 0.83 LMNA (0.56) SMN1; SMN2TP53L3MBTL1RAB9ANPC1
SCHEMBL1854891 0.83 LMNA (0.56) SMN1; SMN2TP53L3MBTL1RAB9ANPC1
SCHEMBL8517905 0.82 AKR1C3 (0.59) RAB9ANPC1KMT2ACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6846900-B2 POLYVALENT CARBOXYLIC ACID ESTER, PROCESS FOR PRODUCING THE CARBOXYLIC ACID ESTER, PLASTIC LENS COMPOSITION USING THE CARBOXYLIC ESTER, PLASTIC LENS OBTAINED BY CURING THE COMPOSITION AND PROCESS FOR PRODUCING THE PLASTIC LENS SHOWA DENKO K.K. (JP) 2005-01-25 US disclosed
US-20030144447-A1 Novel polyvalent carboxylic acid ester and their use in plastic lens compositions SHOW A DENKO K.K. (JP) 2003-07-31 US disclosed
WO-2002079140-A1 NOVEL POLYVALENT CARBOXYLIC ACID ESTERS AND THEIR USE IN PLASTIC LENS COMPOSITIONS SHOWA DENKO K. K. (JP) 2002-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144447-A1 Novel polyvalent carboxylic acid ester and their use in plastic lens compositions VCL, VIM, CRYAA SMN1; SMN2 4503/4885TP53 2999/4885L3MBTL1 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.